Retransplantation in Alport post-transplant anti-GBM disease
Open Access
- 1 February 2004
- journal article
- case report
- Published by Elsevier in Kidney International
- Vol. 65 (2) , 675-681
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- IDENTIFICATION OF ??3, ??4, AND ??5 CHAINS OF TYPE IV COLLAGEN AS ALLOANTIGENS FOR ALPORT POSTTRANSPLANT ANTI-GLOMERULAR BASEMENT MEMBRANE ANTIBODIESTransplantation, 2000
- CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1999
- Alport syndromeKidney International, 1996
- The pathogenesis of Alport syndrome involves type IV collagen molecules containing the α3(IV) chain: Evidence from anti-GBM nephritis after renal transplantationKidney International, 1992
- OUTCOME OF THIRTY PATIENTS WITH ALPORTʼS SYNDROME AFTER RENAL TRANSPLANTATIONTransplantation, 1991
- Failure of two subsequent renal grafts by anti-GBM glomerulonephritis in Alport's syndrome: case report and review of the literatureTransplant International, 1990
- Recurrent Allograft Antiglomerular Basement Membrane Glomerulonephritis in a Patient with Alport’s SyndromeAmerican Journal of Nephrology, 1990
- Identification of variant Alport phenotypes using an Alport-specific antibody probeKidney International, 1989
- Alport’s Syndrome: Risk of Glomerulonephritis Induced by Anti-Glomerular-Basement-Membrane Antibody after Renal TransplantationNephron, 1988
- Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis.Journal of Clinical Investigation, 1986